Identification of imine or enamine drug metabolites using online hydrogen/deuterium exchange and exact mass measurements
作者:Austin C. Li、Erya Yu、Steven C. Ring、James P. Chovan
DOI:10.1002/rcm.6178
日期:2012.4.30
Drugmetabolites that have imine or enamine partial structures cause extra mass‐to‐charge (m/z) increases in onlinehydrogen/deuteriumexchange (HDX) in addition to hydroxyl or amine protons. Online HDX and exactmassmeasurement were used herein to characterize this extra increase property, and to further confirm proposed metabolite structures.
PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
申请人:Trophix Neuroscience Inc.
公开号:EP0918767A1
公开(公告)日:1999-06-02
EP0918767A4
申请人:——
公开号:EP0918767A4
公开(公告)日:2000-04-26
US6001854A
申请人:——
公开号:US6001854A
公开(公告)日:1999-12-14
[EN] PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS<br/>[FR] PRODUIT PHARMACEUTIQUE POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES ET NEUROPSYCHIATRIQUES
申请人:TROPHIX NEUROSCIENCE INC.
公开号:WO1997045423A1
公开(公告)日:1997-12-04
(EN) The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of formulas (I and II) or a pharmaceutically acceptable salt thereof.(FR) Cette invention concerne un produit pharmaceutique destiné au traitement de troubles neurologiques ou neuropsychiatriques. Ledit produit pharmaceutique comprend un composé ayant les formules (I) et (II) ou un sel pharmaceutiquement acceptable dudit composé.